Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of THC on E-Cigarette Use
NCT06609109Phase 1Recruiting
- Sponsor
- Johns Hopkins University
- Start
- Mar 2025
- Primary completion
- Apr 2029
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of dronabinol in Tobacco Use Disorder (TUD) (2 arms), sponsored by Johns Hopkins University. Primary endpoints: Demand Intensity at 45 minutes and Demand Elasticity at 45 minutes. Started Mar 2025; status: recruiting.
02
Drugs
dronabinol
03
Conditions
Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT06609109.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06609109.